The Team
Management & Staff
Giovanni Salerno
CEO
LinkedIn
Our CEO since 2021, Giovanni has more than 20 years’ experience of industrial biotech in Switzerland, USA, Germany and Denmark and has taken several natural molecules to market for both bio-industrial and pharmaceutical applications.
Read full biography
Giovanni spent the several years developing nootkatone as an active ingredient for tick control, obtaining the first registration of a new biopesticide active ingredient by the USA EPA in 20 years. Giovanni has previously worked at Evolva, GARDP (Drugs for Neglected Diseases Initiative), Dako, Cytomation, Imperial College and Pfizer. He has a PhD in Chemical and Pharmaceutical Sciences, University of Trieste. He has worked extensively with US government agencies including the DoD, NIH and BARDA, in particular on resistance to novel pathogens via immune system responses.
Jørn Hansen
Head of Production
LinkedIn
Jørn joined Sundew in September 2020 to lead our production effort. He is an experienced engineer with expertise in product development; equipment design for research and industrial processes; and systematic product development.
Read full biography
Former companies include Amminex (ammonia storage and delivery systems), Haldor Topsøe (catalyst materials). Previously he was head of laboratories at the Danish Technical University. Jørn has a BSc in Mechanical & Chemical Engineering from Copenhagen Technical College
Boqian Wu
Senior Scientist
LinkedIn
Boqian was Sundew’s first employee in January 2020, and is our lead on strain and fermentation development. Since completing a five year postdoc in molecular genetics at the Danish Royal Veterinary and Agricultural University, he has worked at Vipergen, the Carlsberg Lab, Aquaporin and Chreto. Boqian has a PhD, Life Science and Biomedical Engineering, Zhejiang University.
Malte Jarlgaard Hansen
Application Scientist
LinkedIn
Malte is a marine biologist specialized in aquatic and molecular biology . His research has covered the function and application of biomolecules, ecotoxicology, model organisms, and the physiology of plants and animals. Malte finished his Master’s degree at Copenhagen University in 2020.
Mohamed Ibrahim
Research Scientist
LinkedIn
Mohamed is a chemical engineer with a particular focus on process development. Previous companies include Cembrane and Aquaporin. He has Master’s degrees from the Technical University of Denmark (Advanced and Applied Chemical Engineering) and from Universiti Sains in Malaysia (Analytical Chemistry)
Joana Queiroz
Research Scientist
LinkedIn
Joana joined the Sundew team in March 2022 to help develop the company's microalgae-based delivery of RNAi technology. Her research background has established her expertise in molecular biology and cloning. Joana has a Master's degree in Microbiology from the University of Copenhagen.
Milana Maglic Mojic
Research Assistant
LinkedIn
Milana joined the team in March 2022 as a research assistant in fermentation and strain development. She has experience of microbial production of high value products, strain screening and engineering. Milana holds a M. Sc. in Biochemical engineering from the University of Technology Novi Sad, Serbia.
Greg Braun
Research Scientist
LinkedIn
Greg joined Sundew in October 2022, fresh from his MSc in Microbiology at Copenhagen University. He also has an MSc in Biological Sciences from Adam Mickiewicz University in Poznań, Poland
Nick Butler
Research Scientist
LinkedIn
Nick, joined us at the end of 2022 as an intern. We’ve been glad to welcome him to the full-time team to work on our microalgal platform.
He has an MSc in Biotechnology from Copenhagen University, having completed his first degree at Massey University in his native New Zealand.
Board
Neil Goldsmith
Founder
LinkedIn
Neil is a serial biotechnology entrepreneur with 35 years’ experience of the life science sector, having built companies from the ground up in multiple sectors (industrial biotech, therapeutics, lab instrumentation, sensors & diagnostics, services) and countries (UK, Sweden, Denmark, Switzerland, USA, India).
Read full biography
From 2004 to 2017 Neil was founder and CEO of Evolva SA, a pioneering synthetic biology company that scaled multiple products to market, and that went public in Switzerland in 2009. Before that Neil founded, or played a key early role in, amongst others, TopoTarget (cancer therapeutics, IPO Copenhagen), Biotage (microwave chemistry, IPO Stockholm), GX Biosystems (suicide systems for GM microbes), PNA Diagnostics (DNA diagnostics, trade sale to Boehringer Mannheim, now Roche), BIAcore (biosensors, IPO NASDAQ) & Scientific Generics (technology consultancy, IPO LSE). Neil has a 1st class honours degree in Zoology from Oxford University.
Jørgen Hansen
Founder, CTO
LinkedIn
Jørgen is a molecular and fermentation biologist who has worked in the biotech sector for more than 30 years. He has led a large number of industrial biotech programmes, and developed multiple fermentation-derived products from lab scale to multi-tonne scale production and launch.
Read full biography
Jørgen worked for Evolva for 13 years, five of them as CSO where he was responsible for an R&D operation of 120 people worldwide. Prior to Evolva he was with another biotech company, Poalis, developing novel aroma-chemical processes, and before that he held R&D roles with the Danish brewer Carlsberg, including a stint working on a joint Carlsberg-Suntory project.
Jorgen has a PhD in Yeast Genetics from the University of Copenhagen.
Andy Gardiner
Founder
LinkedIn
Andy has worked for twenty-five years with early-stage biotech companies as CEO, CFO, non-executive director and founder. He has run companies in both crop-protection and plant genetics. He recently took an excursion outside biotech, helping to build digital commerce company.
Read full biography
Andy is a former board member of Swedish animal/human vaccine company Isconova (acquired by Novavax) and CEO of UK plant-genetics start-up Norfolk Plant Sciences. Other previous roles include: Personal Chemistry/Biotage (Swe), InSecta (UK/Spain), Isconova (Swe) and Immudex (DK). He is a co-founder (with Neil) of Double Bioventures. Andy has an MBA from London South Bank University and a BSc in Physics from the University of Manchester.
Nicky Deasy
LinkedIn
Nicky is Founder and former Managing Partner at The Yield Lab Europe, one of the largest seed stage agrifood tech impact venture capital funds in Europe, where she headed up the life science and biotech side of the fund's portfolio. She sits on the boards of Microgen Biotech, Micron AgriTech, Solasta Bio and Sundew.
Read full biography
She was Associate Director at KPMG Corporate Finance where she led the food and beverage team, and Director of Corporate Finance at EY, before setting up Alta Corporate Finance, specialising in raising seed stage venture capital for Irish life science technology companies.
Dr John Carrigan
Linkedin
Dr John Carrigan is a scientist with previous experience in academia and as part of start-up founding teams. He has spent a number of years exploiting investment opportunities in emerging technologies across the globe, firstly with SOSV and now as Investment Director at The Yield Lab Europe.
Read full biography
He is an expert advisor to the European Innovation Council and has published peer-reviewed research spanning a range of areas from protein chemistry to bio-based fats and oils. John joined the Sundew Board in April 2022.
Christian Brix Tillegreen (board observer)
Linkedin
Christian is Director of Planetary Health at the BioInnovation Institute in Copenhagen. He has worked with innovative early stage companies for more than ten years, having started his career at Novozymes. Christian is on the Boards of several investee companies, including Biooomix, Cirqle and EvodiaBio.
Read full biography
Christian has a Masters in the Management of Innovation and Business Development from Copenhagen Business School.
Johan Bitsch Nielsen (board observer)
LinkedIn
Johan is an Investment Manager at Denmark’s Export & Investment Fund (Vaekstfonden) with a focus on direct green deeptech investments. Before moving into the world of venture capital, Johan co-founded and developed a couple of successful software startups, most notably Ditmer and FirstAgenda.
Read full biography
Johan has board experience in several companies and is a reserve officer in the Royal Danish Air Force. Johan has a Masters in Management Development from Copenhagen Business School. In his spare time, Johan is a licensed pilot.
Bill Liao (board observer)
Linkedin
Bill Liao is a Chinese-Australian-Irish entrepreneur, investor, former diplomat, business mentor, author, passionate leader and speaker, with a distinguished record in business development and community activism. Bill is a co-founder of the CoderDojo movement and of Weforest.
Read full biography
Bill's career in tech and business encompasses two unicorn companies and launching the world’s first bio-tech accelerator. He is a general partner of SOSV, a venture capital fund of over $1B. Bill is also a founder of the SOSV Momentum Pre-accelerator program. His current focus is Quantum Software.
Advisors
Esben Halkjær Hansen
Co-Founder and Scientific Advisor
LinkedIn
Esben is a molecular biologist with nearly 20 years’ experience developing fermentation-based products and of developing microbial strains. He has lead several projects within this field and taken them from idea phase, though-scale-up and into production.
Read full biography
Formerly Principal Scientist and Program Manager at Evolva. Esben has a PhD in Molecular Biology/Pharmaceutical Science from the University of Copenhagen.
Simon Porphy
Scientific Advisor
LinkedIn
Simon’s key expertise is fermentation science, process development and scale-up. He has more than ten years’ industrial experience, leading several projects from concept stage, through scale-up to the pilot-plant production stage. Previous companies include DuPont and Thermo Fischer. In 2016, he co-founded MicroSynbiotiX with Antonio.
Read full biography
Simon holds a Master’s degree in Biochemical Engineering from the University of Auckland.
Antonio Lamb
Scientific Advisor
LinkedIn
Antonio is a Swedish molecular biologist and entrepreneur from California with expertise in the animal and human pharmaceutical industries. He is a co-founder of MicroSynbiotiX (now acquired by Sundew), developing plant-based oral vaccines and therapeutics for the aquaculture industry.
Read full biography
Antonio obtained his B.Sc. from the University of California, Santa Cruz, his M.Sc. from the University of Basel in molecular biology, and is currently in the Microbiology and Immunology PhD program at the University of Zurich/ETH Zurich. Antonio also works as a scientist at the Novartis Institutes of BioMedical Research, where he conducts CRISPR genetic screening of advanced 3D cell culture models to find new druggable disease targets.
Luc Gruner
Business Development
LinkedIn
Luc began his career as a research scientist at Total, before transitioning into business development. He has forty years’ experience in sales and marketing, strategic planning and in C level roles (CEO, CCO, CBO,), having worked in multinationals as well as family-owned and startup companies.
Read full biography
Luc spent considerable time working in the water treatment, food & beverage and paper/pulp chemical industries but for more than twenty years has worked in biotech in commercial roles. He has been instrumental in negotiating, acquiring and managing partnering projects in markets such as nutrition, feed, F&B, F&F, healthcare, building an extensive network in Asia including Japan. Previous companies include Evolva, VeriZyme, BimKemi, Hercules, BetzDearborn, WR Grace.
Luc has a PhD in physical chemistry from the Université Louis Pasteur, Strasbourg and an AMP from INSEAD.
Kurt Buchmann
Copenhagen University
LinkedIn
Professor of Parasitology and Aquatic Pathobiology at Copenhagen University. Kurt has been researching parasite diseases in fish for the past nearly 40 years, with experience in pathology, immunology, vaccinology, pathogen/host interactions, disease control and aquaculture.
Read full biography
He has developed methods (in vitro and in vivo) to assess the effects of various treatments on a variety of fish diseases. Kurt has a long history of in managing projects and programs (Sustainable Control of Fish Diseases in Aquaculture SCOFDA, Fishnet, Danish Fish Immunology Center and Network DAFINET). He has a PhD in Parasitology from Copenhagen University.
Claus Sternberg
Danish Technical University
LinkedIn
Associate Professor, Department of Bioengineering, DTU. Claus’s main area of research is Microbial Ecology and Physiology, with a particular focus on biofilms and bacteria.
For Sundew, Claus advises on the engineering aspects of scaling up fermentation processes. Claus has extensive experience in collaboration with other academic groups as well as with industry partners.
Niels Henrik Henriksen
Dansk Akvakultur
Niels is a veterinarian who has been a health consultant for Dansk Akvakultur, the umbrella organization for Danish Aquaculture, since 2001.
He has thorough knowledge of the state of health of Danish aquaculture, both conventional and organic, and has conducted field trials regarding water quality and health prevention (vaccination) at a number of Danish aquaculture farms.
Read full biography
His expertise includes all aspects of fish diseases (diagnosis, treatment, prevention and eradication); and EU and national veterinary legislation. He has led and participated in a number of fish disease research projects.
Birger Lindberg Møller
Copenhagen University
LinkedIn
Professor of Plant Biochemistry, University of Copenhagen and Distinguished Professor at the Carlsberg Laboratory.
Research is focused on the role of bio-active natural products in plant growth and development and in resistance to abiotic and biotic stresses.
Read full biography
A significant interest, within the Center for Synthetic Biology, is engineering microalgae, mosses and plant cells into production units for high value natural products. He is an elected member of the Royal Danish Academy of Science and Letters and member of the International Human Rights Network of Academic and Scholarly Societies, Washington.